RYAH Medtech Inc, the medical cannabis and data company, has cemented a deal with a leading pharmaceutical clinic to kick off a research program that will use its dose-measuring vaporizers and dry herb cartridges.
Under the deal’s terms, the undisclosed oncology clinic will analyze the safety of using cannabis and hemp to treat patients in chronic pain, using RYAH’s proprietary devices which allow medical cannabis patients to precisely control dosage and temperature. The clinic has agreed to purchase about 100,000 RYAH dose-measuring dry herb vaporizers and several million dry herb cartridges over five years, starting in December.
“[By] using our best-in-class vaporizers, cartridges and customized software capabilities, the Clinic will capture medically-relevant seed-to-consumption data on its cannabis-based treatments, which will then be analyzed to assess the safety and efficacy of medical cannabis, with the goal of advancing evidence-based policy making,” said Gregory Wagner, RYAH’s CEO.
The new study will include precision dosing and also pave the way for the clinic to track how patients are responding to treatments, with the help of RYAH’s tech.
RYAH, which is headquartered in New York City, will be introducing a customized mobile application and a bit of back-end software for the trial – which will be designed to control temperatures and dosing with precision and direct patient feedback to the clinic.
RYAH uses cartridges pre-filled with either dry herb or concentrate. Users simply scan the cartridge’s QR code, set their parameters and RYAH tracks exactly how much vapor has been inhaled.
The Ryah vaporizer is capable of storing results from vaping sessions to create a picture for doctors and patients of how vaping is working for them and what tweaks — such as cannabis strain, dosage level, frequency or temperature — may need to be made.
“Our vaporizers are smart devices that allow patients to set limits on how much they inhale, track their usage in real time, record how they feel after each session and review their stats over time,” explains Jordan Medley, RYAH’s director of product operations.
News of RYAH’s latest tie-up comes on the heels of its move to set up shop Down Under by striking a distribution agreement with Cannatrek Medical Pty Ltd, a licensed medical cannabis company in Australia.
The deal will see RYAH provide its signature dose-measuring dry herb vaporizers and cartridges to Cannatrek, which will fill them with its proprietary strains and distribute them to patients.